BACKGROUND & AIMS: Stress signaling, both within and outside the endoplasmic reticulum, has been linked to metabolic dysregulation and hepatic steatosis. Methionine-choline-deficient (MCD) diets cause severe fatty liver disease and have the potential to cause many types of cellular stress. The purpose of this study was to characterize hepatic stress in MCD-fed mice and explore the relationship between MCD-mediated stress and liver injury. METHODS: Stress signaling was examined in mice fed MCD formulas for 4-21 days. Signaling also was evaluated in mice fed MCD formulas supplemented with clofibrate, which inhibits hepatic triglyceride accumulation. The role of the pro-apoptotic stress protein C/EBP homologous protein (CHOP) in MCD-mediated liver injury was assessed by comparing the responses of wild-type and CHOP-deficient mice to an MCD diet. RESULTS: MCD feeding caused steatohepatitis coincident with the activation of cJun N-terminal kinase and caspase-12. In contrast, MCD feeding did not activate inositol-requiring protein-1 and actually suppressed the expression of X-box protein-1s. MCD feeding caused weak stimulation of double-stranded RNA-activated protein kinase-like endoplasmic reticulum-resident kinase, but robust activation of general control nonderepressible-2, followed by the phosphorylation of eukaryotic initiating factor-2α and induction of CHOP. Clofibrate eliminated MCD-mediated hepatic steatosis but did not inhibit diet-induced stress. CHOP deficiency did not alleviate, and in fact worsened, MCD-mediated liver disease. CONCLUSIONS: MCD feeding causes an integrated stress response in the liver rather than a classic unfolded protein response. This stress response does not by itself lead to liver injury. CHOP, despite its identity as a mediator of stress-related cell death, does not play a central role in the pathogenesis of MCD-mediated liver disease.
BACKGROUND & AIMS: Stress signaling, both within and outside the endoplasmic reticulum, has been linked to metabolic dysregulation and hepatic steatosis. Methionine-choline-deficient (MCD) diets cause severe fatty liver disease and have the potential to cause many types of cellular stress. The purpose of this study was to characterize hepatic stress in MCD-fed mice and explore the relationship between MCD-mediated stress and liver injury. METHODS: Stress signaling was examined in mice fed MCD formulas for 4-21 days. Signaling also was evaluated in mice fed MCD formulas supplemented with clofibrate, which inhibits hepatic triglyceride accumulation. The role of the pro-apoptotic stress protein C/EBP homologous protein (CHOP) in MCD-mediated liver injury was assessed by comparing the responses of wild-type and CHOP-deficientmice to an MCD diet. RESULTS:MCD feeding caused steatohepatitis coincident with the activation of cJun N-terminal kinase and caspase-12. In contrast, MCD feeding did not activate inositol-requiring protein-1 and actually suppressed the expression of X-box protein-1s. MCD feeding caused weak stimulation of double-stranded RNA-activated protein kinase-like endoplasmic reticulum-resident kinase, but robust activation of general control nonderepressible-2, followed by the phosphorylation of eukaryotic initiating factor-2α and induction of CHOP. Clofibrate eliminated MCD-mediated hepatic steatosis but did not inhibit diet-induced stress. CHOP deficiency did not alleviate, and in fact worsened, MCD-mediated liver disease. CONCLUSIONS:MCD feeding causes an integrated stress response in the liver rather than a classic unfolded protein response. This stress response does not by itself lead to liver injury. CHOP, despite its identity as a mediator of stress-related cell death, does not play a central role in the pathogenesis of MCD-mediated liver disease.
Authors: Heather P Harding; Yuhong Zhang; Huiquing Zeng; Isabel Novoa; Phoebe D Lu; Marcella Calfon; Navid Sadri; Chi Yun; Brian Popko; Richard Paules; David F Stojdl; John C Bell; Thore Hettmann; Jeffrey M Leiden; David Ron Journal: Mol Cell Date: 2003-03 Impact factor: 17.970
Authors: X Z Wang; B Lawson; J W Brewer; H Zinszner; A Sanjay; L J Mi; R Boorstein; G Kreibich; L M Hendershot; D Ron Journal: Mol Cell Biol Date: 1996-08 Impact factor: 4.272
Authors: Michael K Pickens; Jim S Yan; Raymond K Ng; Hisanobu Ogata; James P Grenert; Carine Beysen; Scott M Turner; Jacquelyn J Maher Journal: J Lipid Res Date: 2009-03-17 Impact factor: 5.922
Authors: Bo Feng; Pin Mei Yao; Yankun Li; Cecilia M Devlin; Dajun Zhang; Heather P Harding; Michele Sweeney; James X Rong; George Kuriakose; Edward A Fisher; Andrew R Marks; David Ron; Ira Tabas Journal: Nat Cell Biol Date: 2003-08-10 Impact factor: 28.824
Authors: Mary E Rinella; M Shaddab Siddiqui; Konstantina Gardikiotes; Jeanne Gottstein; Marc Elias; Richard M Green Journal: Hepatology Date: 2011-07-27 Impact factor: 17.425
Authors: Anne S Henkel; Amanda M Dewey; Kristy A Anderson; Shantel Olivares; Richard M Green Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-05-03 Impact factor: 4.052
Authors: Hayato Nakagawa; Atsushi Umemura; Koji Taniguchi; Joan Font-Burgada; Debanjan Dhar; Hisanobu Ogata; Zhenyu Zhong; Mark A Valasek; Ekihiro Seki; Juan Hidalgo; Kazuhiko Koike; Randal J Kaufman; Michael Karin Journal: Cancer Cell Date: 2014-08-14 Impact factor: 31.743
Authors: Yuping Chen; Steve S Choi; Gregory A Michelotti; Isaac S Chan; Marzena Swiderska-Syn; Gamze F Karaca; Guanhua Xie; Cynthia A Moylan; Francesca Garibaldi; Richard Premont; Hagir B Suliman; Claude A Piantadosi; Anna Mae Diehl Journal: Gastroenterology Date: 2012-08-08 Impact factor: 22.682